960 results on '"Smith, Jaclyn A."'
Search Results
2. How often do healthy people cough?
3. Using machine learning models to estimate Escherichia coli concentration in an irrigation pond from water quality and drone-based RGB imagery data
4. Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
5. Productive cough, a forgotten phenotype of refractory chronic cough
6. Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis
7. Functional Collection Programming with Semi-Ring Dictionaries
8. Fisheries observers as enforcement assets: 21 Years of lessons from the North Pacific
9. Scalable Querying of Nested Data
10. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
11. Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough
12. Declarative nested data transformations at scale and biomedical applications
13. An observational study to understand burden and cost of care in adults diagnosed with refractory chronic cough (RCC) or unexplained chronic cough (UCC)
14. Bronchoscopy for refractory/unexplained cough with mucus
15. Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial
16. Novel capsaicin cough endpoints effectively discriminate between healthy controls and patients with refractory chronic cough
17. Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups
18. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough
19. Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study
20. Laryngeal considerations in complex breathlessness
21. High-resolution scRNA-seq reveals genomic determinants of antigen expression hierarchy in African Trypanosomes
22. DNA damage drives antigen diversification through mosaic VSG formation inTrypanosoma brucei
23. Misconceptions on behavioral cough suppression therapy for pediatric nonspecific cough: A response to Weinberger and Buettner's commentary on Fujiki et al.
24. PAciFy Cough—a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough
25. Cough hypersensitivity and chronic cough
26. Effect of traffic-related air pollution on cough in adults with polymorphisms in several cough-related genes
27. The relationship between lung disease severity and the sputum proteome in cystic fibrosis
28. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
29. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
30. Cough Severity Visual Analogue Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis
31. The Therapeutic Landscape in Chronic Cough
32. British Thoracic Society Clinical Statement on chronic cough in adults
33. A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough
34. Advancing Clinical Cohort Selection with Genomics Analysis on a Distributed Platform
35. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
36. Effects of Sampling Time and Depth on Phytoplankton Metrics in Agricultural Irrigation Ponds.
37. Persistent Patterns of E. coli Concentrations in Two Irrigation Ponds from 3 Years of Monitoring
38. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report
39. Acute Cough Due to Acute Bronchitis in Immunocompetent Adult Outpatients: CHEST Expert Panel Report
40. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1)
41. Multiscale spatiotemporal variability of fecal indicator bacteria and associated particle size distributions in the sandy bottom sediments of a Pennsylvania creek
42. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study
43. Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis
44. Improvements in Leicester Cough Questionnaire Subdomains in a Phase 2b Trial of Camlipixant in Refractory Chronic Cough
45. Late Breaking Abstract - Morphine sulfate for the treatment of cough in Idiopathic Pulmonary Fibrosis The PAciFy Cough Randomized Clinical Trial
46. Work productivity and activity impairment among chronic cough patients after a guideline-based treatment in the McMaster Cough Clinic
47. CFTR modulator therapy partially resolves inflammation in CF lung disease
48. Prevalence And Characterization of Cough-Related Urinary Incontinence in A Refractory Chronic Cough Population Enrolled in A Phase 2b Trial of The P2X3 Antagonist, Camlipixant
49. Late Breaking Abstract - Characterising cough in hypersensitivity pneumonitis
50. Gefapixant efficacy and safety in participants with history of refractory or unexplained chronic cough for ≥1 vs <1 year
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.